Lantern Pharma (LTRN) Reports Positive Efficacy Data of LP-284 in Hematologic Cancers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| (NASDAQ: LTRN) | Delayed: 0.64 -0.03 (4.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $ | |||
| Open | $0.65 | 52 Week Low | $ | |||
| Day High | $0.72 | P/E | N/A | |||
| Day Low | $0.64 | EPS | $ | |||
| Volume | 105,811 | |||||
